Home Canonic

Canonic

In operation
-
Medical Cannabis Product Developer

Basic Information

Canonic is a subsidiary of Evogene. Canonic leverages Evogene's proprietary GeneRator AI engine to develop medical cannabis products. The company’s development efforts focus on enhancing active compounds, genetic stability, and the specific medical effects of cannabis strains. Additionally, the company’s strategy includes developing cannabis varieties to commercialize medical cannabis products independently or through collaborations.
Canonic, Ltd.
Israel
less than 15 people
April 01, 2019
info@canonicbio.com